Combination Diabetes Drug Approved


The FDA has approved a combination tablet consisting of sitagliptin and metformin hydrochloride (Janumet XR, Merck) to treat type 2 diabetes. The once-daily agent is indicated as an adjunct to diet and exercise to improve glycemic control.

Abstract: Merck.

Submit a Comment

Your email address will not be published. Required fields are marked *

seven + eighteen =